Coffee Holding (JVA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
15 Sep, 2026Executive summary
The annual meeting will be held virtually on October 28, 2026, with shareholders able to vote and submit questions online.
Shareholders will vote on electing one director, ratifying the appointment of the independent auditor, and an advisory vote on executive compensation.
The Board recommends voting in favor of all proposals and has provided detailed proxy materials online.
Voting matters and shareholder proposals
Proposal 1: Election of David Gordon as director for a three-year term expiring in 2029.
Proposal 2: Ratification of CBIZ CPAs P.C. as the independent registered public accounting firm for fiscal year ending October 31, 2026.
Proposal 3: Advisory (non-binding) vote on executive compensation (say-on-pay).
Shareholders of record as of September 1, 2026, are entitled to vote; voting can be done online, by phone, fax, or mail.
Deadlines and procedures for submitting shareholder proposals for the 2027 meeting are specified.
Board of directors and corporate governance
The Board consists of six members, with a majority being independent under Nasdaq rules.
Board committees include Audit, Compensation, and Nominating and Corporate Governance, all comprised of independent directors.
The Board held eight meetings in fiscal 2025; directors are expected to attend all meetings.
The company has adopted a Code of Conduct and Ethics, anti-hedging, and insider trading policies.
Latest events from Coffee Holding
- Annual meeting to vote on director election, auditor ratification, and executive pay.JVA
Proxy filing - Net income rebounded to $2.0M in Q3 2026 on higher margins and full debt repayment.JVA
Q3 2026 - Quarterly net sales fell 5.1% on coffee price declines, but new business supports future margins.JVA
Q2 2026 - Net sales and net income per share rose sharply, driven by acquisitions and operational efficiencies.JVA
Q1 2026 - Net sales up 15% and profitability restored, with strong outlook for 2025 amid cost controls.JVA
Q4 2024 - EPS up to $0.11, sales and margins rose, annual dividend resumed, risks and remediation ongoing.JVA
Q2 2025 - Q3 2024 saw 19% sales growth, margin expansion, and a return to profitability.JVA
Q3 2024 - Net sales up 27%, but Q3 net loss driven by $2.2M derivative losses; Q4 outlook positive.JVA
Q3 2025 - Net sales and EPS rose 9% and tripled, with improved margins and positive net income.JVA
Q1 2025